Crossmark

Assessment of plasma endocan for the prediction of mortality in COVID-19 patients undergoing veno-venous ECMO: A pilot study

Crossref DOI link: https://doi.org/10.1016/j.medine.2022.04.018

Published Print: 2023-01

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Levy, C.

Dognon, N.

Normandin, S.

Duburcq, T.

Gaudet, A.

Parmentier-Decrucq, Erika

Poissy, Julien

Dubucquoi, Sylvain

Boddaert, Pauline

Caplan, Morgan

Goutay, Julien

Durand, Arthur

Graffin, Benoit

Gaudel, Myrtille

Detollenaere, Charles

Gueguen, Ines

Ceunebroek, Marine Van

Tortuyaux, Romain

Saura, Ouriel

Kalioubie, Ahmed El

Favory, Raphael

Girardie, Patrick

Houard, Marion

Jaillette, Emmanuelle

Jourdain, Mercedes

Ledoux, Geoffrey

Mathieu, Daniel

Moreau, Anne Sophie

Nseir, Saad

Onimus, Thierry

Preau, Sebastien

Robriquet, Laurent

Rouze, Anahita

Six, Sophie

Soquet, Jerome

Loobuyck, Valentin

Mugnier, Agnes

Vincentelli, André
License Information

Text and Data Mining valid from 2023-01-01
More Information

This article is maintained by: Elsevier

Article Title: Assessment of plasma endocan for the prediction of mortality in COVID-19 patients undergoing veno-venous ECMO: A pilot study

Journal Title: Medicina Intensiva (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.medine.2022.04.018

Content Type: simple-article

Copyright: © 2022 Elsevier España, S.L.U. and SEMICYUC. All rights reserved.